4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-036970
Chief Business Officer sold 5,000 shares at $26.03 ($130,150)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2022-11-22 | Sale | −4,814 | $26.03 | $125,308 | 21,329 | D: show line 1 in the form |
| Robb Gary Charles Chief Business Officer | 2022-11-23 | Sale | −186 | $26.03 | $4,842 | 21,143 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $26.03 · $130,150 | |||||||
Loading xslF345X03/doc4.xml…